Nancy E. Davidson, MD, director of clinical oncology for the Fred Hutch/University of Washington Cancer Consortium, and resident of Seattle Cancer Care Alliance, is a world-renowned breast cancer researcher whose work focuses on clinical and translational breast cancer research and cancer biology and treatment. She is known for her studies involving the role of hormones and the estrogen receptor in breast carcinogenesis that have defined the molecular mechanisms driving the disease as well as for her efforts to establish novel therapeutic approaches for patients who fail to respond to common treatment modalities. She has led clinical trials involving chemotherapy and endocrine-related therapies for treating premenopausal breast cancer and optimal chemotherapy for early breast cancer.
Davidson has been actively involved in the AACR since 1988. She is an editorial board member of Cancer Prevention Research and has served on numerous other boards and committees, the most recent of which are: member of the AACR Distinguished Lectureship in Breast Cancer Research Award Committee (2012); chair (2011) and member (2010) of the Nominating Committee; member of the AACR Outstanding Investigator Award for Breast Cancer Research Committee (2010); member of the Continuing Medical Education Committee (2009-2014); chair of the Breast Cancer Research Foundation-AACR Grants for Translational Breast Cancer Research Scientific Review Committee (2009); member of the Dorothy P. Landon-AACR Prize for Translational Cancer Research Committee (2009); chair (2008-2010) and member (2005) of the Research Grant Review Committee; member of the Stand Up To Cancer Innovative Research Grants Scientific Review Committee (2008-2009); member of the Scientific Program Committee for the AACR International Conference on Frontiers in Cancer Prevention Research (2008); and member of the AACR Award for Lifetime Achievement in Cancer Research Committee (2005). She was elected by the membership as a member of the AACR board of directors (2002-2005).
She has been recognized with myriad honors and awards throughout her career, including the AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship, the Potamkin Award from the Pennsylvania Breast Cancer Coalition, the Gianni Bonadonna Breast Cancer Award from the American Society of Clinical Oncology (ASCO), the Distinguished Alumna Award from Johns Hopkins University Alumni Association, and the Rosalind E. Franklin Award for Women in Science from the National Cancer Institute (NCI). She is an elected member of the Institute of Medicine, the Association of American Physicians, and the American College of Physicians. Davidson is also a past president and former board member of ASCO and currently serves as a member of the scientific advisory boards for Breast Cancer Research Foundation, V Foundation for Cancer Research, and Sidney Kimmel Foundation for Cancer Research.
Prior to joining the Fred Hutch/University of Washington Cancer Consortium, Davidson served as director of the University of Pittsburgh Cancer Institute. Previously, she was professor of oncology at Johns Hopkins University School of Medicine and director of the Breast Cancer Program at Johns Hopkins Oncology Center. Early in her career, she was a research assistant professor of pharmacology at the Uniformed Services University of Health Sciences.
Davidson received a bachelor’s degree in molecular biology from Wellesley College in Wellesley, Massachusetts, and a medical degree from Harvard Medical School in Boston. She completed an internship at the Hospital of the University of Pennsylvania in Philadelphia, an internal medicine residency at Johns Hopkins Hospital, and a medical oncology fellowship at the NCI.